Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
AEN
REST API REST API
Homo sapiens
AEN is differentially expressed in 208 experiments: 86 organism parts: kidney, lung, ... (84 more);, 141 disease states: normal, glioblastoma, ... (139 more);, 55 cell types 280 cell lines 28 compound treatments and 62 other conditions.
Synonyms ISG20L1, FLJ12484, FLJ12562
Orthologs REX4 (Saccharomyces cerevisiae)   Aen (Rattus norvegicus)   F6QDM2_CIOIN (Ciona intestinalis)   AEN (Bos taurus)   Aen (Mus musculus)   AEN (Gallus gallus)   isg20l2 (Danio rerio)   aen (Xenopus laevis)   AL954306.1 (Danio rerio)   AEN (Canis familiaris)   (Compare orthologs)
InterPro Term Exonuclease_RNaseT/DNA_pol3, Exonuclease
Gene Ontology Term apoptosis, intracellular, nucleic acid binding, response to ionizing radiation, DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis, nucleus, hydrolase activity, nucleoplasm, response to DNA damage stimulus, exonuclease activity, nucleolus
UniProt Accession Q8WYW8, Q8WTP8
Search EB-eye ENSG00000181026
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-GEOD-22541, E-MEXP-1251, E-MTAB-24, ... (18 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-19639, E-GEOD-2450, E-MTAB-62, E-GEOD-7182, ... (25 experiments)

Factor Value U/D Experiments
AGS
2
E-GEOD-15460, E-MTAB-37
HCC1937
2
E-MTAB-37, E-MTAB-62
C3A
1
E-MTAB-37
HCC1395
1
E-MTAB-37
CORL279
1
E-MTAB-37
lncap cells
1
E-MTAB-62
274 more value(s).


Cell type

studied in E-GEOD-22529, E-GEOD-20193, E-GEOD-20677, E-GEOD-13987, E-TABM-34, ... (31 experiments)

Factor Value U/D Experiments
memory B cell
2
E-TABM-702, E-MEXP-2360
CD71+ early erythroid
2
E-AFMX-5, E-TABM-145
naive B cell
1
E-TABM-702
hMOF knock-down
1
E-GEOD-20193
B lymphocyte
1
E-GEOD-6691
CD8+ T cell
1
E-GEOD-6740
49 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-22529, E-GEOD-15960, E-GEOD-1869, ... (43 experiments)

Factor Value U/D Experiments
cervical carcinoma
2
E-MTAB-62, E-MTAB-37
colon carcinoma
2
E-MTAB-62, E-GEOD-3726
multiple myeloma
2
E-MTAB-62, E-GEOD-6691
polymyositis
1
E-MTAB-62
myositis
1
E-MTAB-62
squamous cell carcinoma cell line, 2h after infection with fasX-mutant Streptococcus pyogenes
1
E-MTAB-62
135 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-4668, E-GEOD-1417, E-TABM-782, E-GEOD-3720, ... (22 experiments)

Factor Value U/D Experiments
bacterial endotoxin
1
E-GEOD-3284
sevoflurane
1
E-GEOD-4386
CNOT7 + non-targeting
1
E-MEXP-2218
DMSO
1
E-MEXP-1561
MIG control
1
E-GEOD-15811
ethanol
1
E-MEXP-2241
22 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-TABM-325

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-7967, E-TABM-125, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-MEXP-1251, E-GEOD-19246, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-5999, E-GEOD-20033, E-MEXP-958, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-3325, E-GEOD-22541

Environmental stress
studied in E-GEOD-1518, E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MTAB-73, E-MEXP-1482

Genotype
studied in E-TABM-1029, E-MEXP-149, E-GEOD-21750, E-TABM-868, E-TABM-601, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-MEXP-2657, E-TABM-127, E-MEXP-1273, E-MEXP-2146

Histology
studied in E-TABM-276, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-TABM-666, E-GEOD-19519, ... (19 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-MEXP-561 ... (5 experiments)

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-21750, E-GEOD-1460, E-GEOD-17636, E-GEOD-4600 ... (5 experiments)

Progesterone receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-19445, E-GEOD-19246, E-GEOD-1343

Replicate
studied in E-GEOD-18791

RNAi
studied in E-MEXP-2115, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, E-MEXP-2759 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-18995

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643

Stimulation
studied in E-GEOD-20114

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-4922

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-MEXP-973, E-GEOD-19246, E-GEOD-12198

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-22541, E-GEOD-1561

Vehicle
studied in E-GEOD-5258

Processing time: 0.37 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM